Core Cap Advisors, LLC Nls Pharmaceutics Ltd. Transaction History

Core Cap Advisors, LLC

  • $2.39 Billion
  • Q2 2025

A detailed history of Core Cap Advisors, LLC transactions in Nls Pharmaceutics Ltd. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 36 shares of NLSP stock, worth $78. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36
Holding current value
$78
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$1.35 - $2.9 $48 - $104
36 New
36 $0

Others Institutions Holding NLSP

# of Institutions
1
Shares Held
36
Call Options Held
0
Put Options Held
0
View Full List

About NLS Pharmaceutics Ltd.

NLSP Quotes by TradingView
  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $64.3M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email